Erlotinib HCl (OSI-774)

DRUG2 trials

Sponsors

Genentech, Inc.

Conditions

Breast CancerGlioblastoma

Phase 2

A Study to Evaluate Erlotinib in Patients With Advanced or Metastatic Breast Cancer During or Following Chemotherapy

CompletedNCT00109265

Genentech, Inc.Breast Cancer

Start: 2001-05-31End: 2002-10-31Updated: 2015-07-02

A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)

CompletedNCT00337883

Genentech, Inc.Glioblastoma

Start: 2003-07-31End: 2005-10-31Target: 110Updated: 2014-03-04